Literature DB >> 8232926

Subtle extrapyramidal signs can predict the development of dementia in elderly individuals.

M Richards1, Y Stern, R Mayeux.   

Abstract

To assess the significance of mild extrapyramidal signs (EPSs) in aging, we prospectively followed 228 elderly individuals without dementia or major neurologic disease at baseline. Seventy-three (32%) showed mild idiopathic EPSs at baseline assessment and 32 (14%) of these 228 individuals met NINCDS-ADRDA criteria for probable or possible Alzheimer's disease on follow-up. While none of these individuals developed Parkinson's disease, those with more than one EPS at baseline were significantly more likely to become demented during follow-up than were those with one or no EPS, an association not confounded by age, education, or gender. Individuals with more than one EPS and with cognitive impairment (CI) at baseline were at highest risk for dementia. EPSs were also independently associated with incident dementia in the absence of CI at baseline. We conclude that mild EPSs are a significant predictor of dementia in elderly individuals.

Entities:  

Mesh:

Year:  1993        PMID: 8232926     DOI: 10.1212/wnl.43.11.2184

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  Odor identification and progression of parkinsonian signs in older persons.

Authors:  Robert S Wilson; Steven E Arnold; Aron S Buchman; Yuxiao Tang; David A Bennett
Journal:  Exp Aging Res       Date:  2008 Jul-Sep       Impact factor: 1.645

2.  Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study.

Authors:  Florence Portet; Nikolaos Scarmeas; Stephanie Cosentino; Elisabeth P Helzner; Yaakov Stern
Journal:  Arch Neurol       Date:  2009-09

Review 3.  North of England evidence based guidelines development project: guideline for the primary care management of dementia.

Authors:  M Eccles; J Clarke; M Livingstone; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-09-19

4.  Clinical characteristics related to worsening of motor function assessed by the Unified Parkinson's Disease Rating Scale in the elderly population.

Authors:  Inga Liepelt-Scarfone; Stefanie Lerche; Stefanie Behnke; Jana Godau; Alexandra Gaenslen; Christoph Pausch; Klaus Fassbender; Kathrin Brockmann; Karin Srulijes; Heiko Huber; Isabel Wurster; Daniela Berg
Journal:  J Neurol       Date:  2014-12-02       Impact factor: 4.849

5.  Nigral pathology and parkinsonian signs in elders without Parkinson disease.

Authors:  Aron S Buchman; Joshua M Shulman; Sukriti Nag; Sue E Leurgans; Steven E Arnold; Martha C Morris; Julie A Schneider; David A Bennett
Journal:  Ann Neurol       Date:  2012-02       Impact factor: 10.422

6.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

7.  Parkinson's Disease-Related Motor and Nonmotor Symptoms in the Lancaster Amish.

Authors:  Michael D F Goldenberg; Xuemei Huang; Honglei Chen; Lan Kong; Teodor T Postolache; John W Stiller; Katherine A Ryan; Mary Pavlovich; Toni I Pollin; Alan R Shuldiner; Richard B Mailman; Braxton D Mitchell
Journal:  Neuroepidemiology       Date:  2020-07-31       Impact factor: 3.282

8.  Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons.

Authors:  Patricia A Boyle; Aron S Buchman; Robert S Wilson; Sue E Leurgans; David A Bennett
Journal:  Arch Neurol       Date:  2009-11

9.  Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy.

Authors:  Victor Valcour; Michael R Watters; Andrew E Williams; Ned Sacktor; Aaron McMurtray; Cecilia Shikuma
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

10.  Parkinsonism in Older Adults and Its Association With Adverse Health Outcomes and Neuropathology.

Authors:  Aron S Buchman; R S Wilson; Joshua M Shulman; Sue E Leurgans; Julie A Schneider; David A Bennett
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-09-10       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.